| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NI1294 |
| P8608 | Fatcat ID | release_mwncg2h3ura3tlstodi6ybroa4 |
| P3181 | OpenCitations bibliographic resource ID | 4875041 |
| P698 | PubMed publication ID | 16378096 |
| P5875 | ResearchGate publication ID | 7393413 |
| P2093 | author name string | Gang Pei | |
| Yalan Wu | |||
| Xiaohui Zhao | |||
| Yaya Wang | |||
| Lin Teng | |||
| Yawei Tang | |||
| P2860 | cites work | A Toll-like receptor recognizes bacterial DNA | Q24290668 |
| TAK1 is a ubiquitin-dependent kinase of MKK and IKK | Q24291454 | ||
| TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2 | Q24292505 | ||
| Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3... | Q24297037 | ||
| Distinct molecular mechanism for initiating TRAF6 signalling | Q24302174 | ||
| An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior | Q24310712 | ||
| Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta | Q24311833 | ||
| Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling | Q24320156 | ||
| The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes | Q24338639 | ||
| Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways | Q24338654 | ||
| Toll-like receptor signalling | Q24570126 | ||
| Toll-like receptors | Q27860671 | ||
| Innate immune recognition | Q27860721 | ||
| VISA is an adapter protein required for virus-triggered IFN-beta signaling | Q28131814 | ||
| Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3 | Q28138462 | ||
| Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain | Q28142613 | ||
| Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin | Q28190513 | ||
| Tumor necrosis factor receptor-associated factors (TRAFs) | Q28199382 | ||
| CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members | Q28201693 | ||
| Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB | Q28201706 | ||
| The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination | Q28201717 | ||
| Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4 | Q28205234 | ||
| Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR | Q28212718 | ||
| Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2 | Q28218131 | ||
| Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2 | Q28299947 | ||
| Enhanced morphine analgesia in mice lacking beta-arrestin 2 | Q28504554 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence | Q28590279 | ||
| Activators and target genes of Rel/NF-kappaB transcription factors | Q29547882 | ||
| The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses | Q29616349 | ||
| Negative regulation of toll-like receptor-mediated immune responses | Q29619019 | ||
| Regulation of tyrosine kinase cascades by G-protein-coupled receptors. | Q33597362 | ||
| beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. | Q34513767 | ||
| Arresting developments in heptahelical receptor signaling and regulation | Q34540902 | ||
| Toll-like receptor signaling | Q35189960 | ||
| beta-arrestins: traffic cops of cell signaling | Q35804809 | ||
| The role of TRAF6 in signal transduction and the immune response | Q35957616 | ||
| Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway | Q47073322 | ||
| Toll-like receptor signaling pathways | Q73490994 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| toll-like receptor | Q408004 | ||
| TNF receptor associated factor 6 | Q4050614 | ||
| TNF receptor associated factor 2 | Q7671245 | ||
| protein autoubiquitination | Q14860462 | ||
| Arrestin beta 2 | Q21109248 | ||
| Arrestin beta 1 | Q21109259 | ||
| Arrestin, beta 2 | Q21493917 | ||
| TNF receptor-associated factor 6 | Q21497539 | ||
| P304 | page(s) | 139-47 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling | |
| P478 | volume | 7 |
| Q30840655 | A Comprehensive View of the β-Arrestinome. |
| Q64079625 | A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy |
| Q47716701 | A synthetic intrabody-based selective and generic inhibitor of GPCR endocytosis |
| Q38736590 | ARRDC4 regulates enterovirus 71-induced innate immune response by promoting K63 polyubiquitination of MDA5 through TRIM65. |
| Q34295408 | Activation of N-methyl-d-aspartate receptor downregulates inflammasome activity and liver inflammation via a β-arrestin-2 pathway |
| Q34126284 | Allelic variation on murine chromosome 11 modifies host inflammatory responses and resistance to Bacillus anthracis |
| Q24310297 | An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells |
| Q42576987 | An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production |
| Q35924613 | Analysis of the immune-related transcriptome of a lophotrochozoan model, the marine annelid Platynereis dumerilii. |
| Q64254600 | Anti-apoptotic Mutations Desensitize Human Pluripotent Stem Cells to Mitotic Stress and Enable Aneuploid Cell Survival |
| Q35565885 | Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways |
| Q40159254 | Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. |
| Q42089456 | Arrestins in apoptosis |
| Q37321957 | Arrestins in host-pathogen interactions |
| Q21184142 | Arrestins: ubiquitous regulators of cellular signaling pathways |
| Q36964334 | Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation |
| Q43861679 | Beta-arrestin 2 negatively regulates sepsis-induced inflammation |
| Q35150208 | Beta-arrestin-1 protein represses adipogenesis and inflammatory responses through its interaction with peroxisome proliferator-activated receptor-gamma (PPARgamma) |
| Q35150203 | Beta-arrestin-1 protein represses diet-induced obesity |
| Q42420177 | Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. |
| Q29616793 | Beta-arrestins and cell signaling |
| Q33890802 | Beyond desensitization: physiological relevance of arrestin-dependent signaling. |
| Q38287022 | Bioactive dietary peptides and amino acids in inflammatory bowel disease |
| Q35565857 | CD14 and complement crosstalk and largely mediate the transcriptional response to Escherichia coli in human whole blood as revealed by DNA microarray |
| Q33701850 | CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation |
| Q41382247 | CO2 pneumoperitoneum preserves β-arrestin 2 content and reduces high mobility group box-1 (HMGB-1) expression in an animal model of peritonitis. |
| Q38898242 | Cardiac ubiquitin ligases: Their role in cardiac metabolism, autophagy, cardioprotection and therapeutic potential |
| Q81798763 | Chemical biology in China takes on signal transduction |
| Q42263287 | Chronic stress promotes lymphocyte reduction through TLR2 mediated PI3K signaling in a β-arrestin 2 dependent manner |
| Q80584784 | Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1 |
| Q36636243 | Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1 |
| Q28301043 | Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages |
| Q38122815 | Emerging roles of E3 ubiquitin ligases in autophagy |
| Q37980726 | Endocytosis and signaling: cell logistics shape the eukaryotic cell plan |
| Q41952624 | Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis |
| Q39193257 | G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms |
| Q24630455 | GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects |
| Q37035987 | Gene dosage-dependent negative regulatory role of β-arrestin-2 in polymicrobial infection-induced inflammation. |
| Q39669210 | Genome-wide association study among four horse breeds identifies a common haplotype associated with in vitro CD3+ T cell susceptibility/resistance to equine arteritis virus infection |
| Q28539905 | IIS--Integrated Interactome System: a web-based platform for the annotation, analysis and visualization of protein-metabolite-gene-drug interactions by integrating a variety of data sources and tools |
| Q35841971 | Identification of a nuclear localization sequence in β-arrestin-1 and its functional implications |
| Q36637874 | IkappaB kinase complexes: gateways to NF-kappaB activation and transcription |
| Q40112532 | Immunology in China: the past, present and future |
| Q35490940 | Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation |
| Q61796045 | Indispensable role of β-arrestin2 in the protection of remifentanil preconditioning against hepatic ischemic reperfusion injury |
| Q47999107 | Loss of β-arrestin 2 exacerbates experimental autoimmune encephalomyelitis with reduced number of Foxp3+ CD4+ regulatory T cells |
| Q41721776 | Loss of β-arrestin-2 and Activation of CXCR2 Correlate with Lymph Node Metastasis in Non-small Cell Lung Cancer |
| Q37354227 | MSC p43 required for axonal development in motor neurons. |
| Q51270292 | Macrophages and the Recovery from Acute and Chronic Inflammation. |
| Q41471053 | MicroRNA-155 attenuates late sepsis-induced cardiac dysfunction through JNK and β-arrestin 2. |
| Q38994595 | Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins |
| Q34126537 | Molecular basis of lysophosphatidic acid-induced NF-κB activation |
| Q26785883 | Multifaceted role of β-arrestins in inflammation and disease |
| Q38478625 | NF-κB, a hot topic in biochemical and medical studies in China |
| Q24295288 | NUMBL interacts with TRAF6 and promotes the degradation of TRAF6 |
| Q40325258 | NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6/TLR-IL-1R signalling axis |
| Q36678037 | New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors |
| Q34803242 | Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways |
| Q36505726 | Non-Hematopoietic β-Arrestin1 Confers Protection Against Experimental Colitis. |
| Q33978110 | Nonhematopoietic β-Arrestin-1 inhibits inflammation in a murine model of polymicrobial sepsis. |
| Q37367885 | Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response |
| Q58801877 | Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function |
| Q36528962 | Nur77-mediated TRAF6 signalling protects against LPS-induced sepsis in mice |
| Q28304837 | Physiologic and cardiac roles of beta-arrestins |
| Q37356068 | Physiological and pharmacological implications of beta-arrestin regulation. |
| Q41935577 | Posttranslational Modification Control of Inflammatory Signaling |
| Q36303508 | Protective Role of β-arrestin2 in Colitis Through Modulation of T-cell Activation. |
| Q24336085 | Protein kinase Cdelta binds TIRAP/Mal to participate in TLR signaling |
| Q24303616 | RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation |
| Q37320596 | Regulation of Toll signaling and inflammation by β-arrestin and the SUMO protease Ulp1. |
| Q37769479 | Regulation of Toll-like receptor signaling in the innate immunity |
| Q33564436 | Regulation of amygdalar PKA by beta-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning |
| Q39131811 | Regulation of inflammation by β-arrestins: Not just receptor tales |
| Q34091848 | Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins |
| Q36839862 | Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors |
| Q51354405 | Role of β2-adrenoceptor-β-arrestin2-nuclear factor-κB signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis. |
| Q37143647 | SHIP prevents lipopolysaccharide from triggering an antiviral response in mice |
| Q35002768 | SUMOylation attenuates human β-arrestin 2 inhibition of IL-1R/TRAF6 signaling |
| Q34639822 | Surfactant protein-A modulates LPS-induced TLR4 localization and signaling via β-arrestin 2 |
| Q34786821 | TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. |
| Q89878907 | TLR2 Signaling Pathway Combats Streptococcus uberis Infection by Inducing Mitochondrial Reactive Oxygen Species Production |
| Q52661592 | TRAF molecules in inflammation and inflammatory diseases. |
| Q37769438 | TRAF-mediated regulation of immune and inflammatory responses |
| Q34199975 | TRAF6 mediates IL-1β/LPS-induced suppression of TGF-β signaling through its interaction with the type III TGF-β receptor |
| Q28593493 | TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation |
| Q39381430 | The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling |
| Q33790179 | The GTPase-activating protein GIT2 protects against colitis by negatively regulating Toll-like receptor signaling |
| Q36965348 | The interleukin-1 receptor associated kinase 1 contributes to the regulation of NFAT |
| Q36875508 | The negative regulation of Toll-like receptor and associated pathways |
| Q28589455 | The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors |
| Q47328865 | The role and mechanism of β‑arrestins in cancer invasion and metastasis (Review). |
| Q34490165 | The ubiquitin ligase TRAF6 negatively regulates the JAK-STAT signaling pathway by binding to STAT3 and mediating its ubiquitination |
| Q36773331 | Therapeutic potential of β-arrestin- and G protein-biased agonists. |
| Q98177723 | Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility |
| Q37188449 | Toll-like receptor 4 mediates chronic restraint stress-induced immune suppression |
| Q37498029 | Toll-like receptor 9 is required for chronic stress-induced immune suppression |
| Q37265030 | Toll-like receptors in skin infections and inflammatory diseases. |
| Q38925152 | Toll-like receptors: promising therapeutic targets for inflammatory diseases |
| Q36663074 | Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. |
| Q35748571 | Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses |
| Q36755025 | Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation |
| Q35077552 | Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling |
| Q34788975 | Venom of the ectoparasitoid, Nasonia vitripennis, influences gene expression in Musca domestica hemocytes |
| Q36202827 | Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. |
| Q37000177 | beta-Arrestin 2: a Negative Regulator of Inflammatory Responses in Polymorphonuclear Leukocytes |
| Q33915868 | beta-Arrestins modulate Adenovirus-vector-induced innate immune responses: differential regulation by beta-arrestin-1 and beta-arrestin-2. |
| Q83226645 | β-Arrestin 1 modulates functions of autoimmune T cells from primary biliary cirrhosis patients |
| Q34044736 | β-Arrestin 2 negatively regulates Toll-like receptor 4 (TLR4)-triggered inflammatory signaling via targeting p38 MAPK and interleukin 10. |
| Q39692884 | β-Arrestin-1 deficiency protects mice from experimental colitis. |
| Q37353973 | β-Arrestin-2 modulates radiation-induced intestinal crypt progenitor/stem cell injury |
| Q38902143 | β-Arrestin2 Contributes to Cell Viability and Proliferation via the Down-Regulation of FOXO1 in Castration-Resistant Prostate Cancer |
| Q38136811 | β-Arrestins 1 and 2 are critical regulators of inflammation. |
| Q36755034 | β-Arrestins Negatively Regulate the Toll Pathway in Shrimp by Preventing Dorsal Translocation and Inhibiting Dorsal Transcriptional Activity |
| Q38114223 | β-Arrestins in the immune system |
| Q37810522 | β-Arrestins: multifunctional signaling adaptors in type 2 diabetes |
| Q103001437 | β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion |
| Q49633147 | β-arrestin 2 attenuates lipopolysaccharide-induced liver injury via inhibition of TLR4/NF-κB signaling pathway-mediated inflammation in mice |
| Q64111960 | β-arrestin 2 negatively regulates NOD2 signalling pathway through association with TRAF6 in microglia after cerebral ischaemia/reperfusion injury |
| Q45167801 | β-arrestin 2 regulates Toll-like receptor 4-mediated apoptotic signalling through glycogen synthase kinase-3β. |
| Q34540603 | β-arrestin 2-mediated immune suppression induced by chronic stress |
| Q34827316 | β-arrestin2 in infiltrated macrophages inhibits excessive inflammation after myocardial infarction |
| Q37550036 | β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury |
Search more.